Skip to main content
Caplight Logo









Bio-Sourcing

Bio-Sourcing

Private
LiègeHealthcare & Life Scienceshttps://www.bio-sourcing.com/

Last Round

Grant

Jan 12, 2026

Total Funding Raised

$22.17M

Company Overview

Bio-Sourcing is a biotechnology company that develops a platform for producing biotherapeutics, such as monoclonal antibodies, in the milk of genetically engineered goats.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

biomanufacturingtherapeutic proteinsoral monoclonal antibodybiologicsbiopharmadrug delivery platformmolecular farmingbiotech platformprotein expressioncontract manufacturingpharmaceutical R&Dbiotech partnershippharma tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bio-Sourcing Comparables

Compare Bio-Sourcing with similar companies based on industry and business-model similarity.

Bio-Sourcing comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LFB Group
76%
Baiya Phytopharm
76%
KBio Inc.
74%

Bio-Sourcing Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 12, 2026
AcceleratorSep 24, 2024
VC RoundSep 24, 2024
GrantMay 28, 2024
Series ANov 7, 2014

Key People

Founding team and executive leadership

Bertrand Mérot

CEO

Executive Team

Maxime Wallerand

CFO

Executive Team

Brigitte Genard

COO

Executive Team

Bio-Sourcing Investors

Notable investors and investment history

Bio-Sourcing investors
InvestorRounds
Innovate UKGrant
Public service of WalloniaGrant
Luxembourg DéveloppementSeries A
NoshaqSeries A
InvestsudSeries A
Eurostars SME programmeGrant
Agipi InnovationSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Grew 20% QoQ, from 25 to 30 employees.

  • Mar 20, 2026

    Partnering with The Tiny Cargo Company on new antibody therapies.

Bio-Sourcing Filings

Explore SEC and related filing metadata, where available.

Bio-Sourcing filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Bio-Sourcing's valuation, stock price, and market status.

Is Bio-Sourcing a public or private company?

Bio-Sourcing is a private company.

What is the current stock price of Bio-Sourcing?

Bio-Sourcing is a private company with no public stock price. No recent secondary market data is available.

How much is Bio-Sourcing worth (valuation)?

Valuation information for Bio-Sourcing is not publicly available.

Can I buy Bio-Sourcing stock?

Bio-Sourcing shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Bio-Sourcing's last funding round?

Bio-Sourcing's most recent funding round was VC Round on September 24, 2024.

Who are the main investors in Bio-Sourcing?

Key investors in Bio-Sourcing include European Innovation Council (EIC) Accelerator.

Will Bio-Sourcing IPO soon?

No public IPO plans have been announced for Bio-Sourcing.

How can I track Bio-Sourcing secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bio-Sourcing's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLiège
Employee Range30
Year Founded2014
Last FundingJan 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?